bioRxivImmunologyPreprint
Impact of IL-21 on Natural Killer cell proliferation and Function - a mathematical and functional assessment
R. Biondo, I. Nayak, N. Möker, C. Zhang, W. C. Stewart, S. I. Khakoo, J. Das
Abstract
Natural killer (NK) cells are currently in use as immunotherapeutic agents for cancer. Many different cytokines are used to generate NK cells including IL-2, IL-12, IL-15 and IL-18 in solution and membrane bound IL-21. These cytokines drive NK cell activation through the integration of STAT and NF-{kappa}B pathways, which overlap and synergize, making it challenging to predict optimal cytokine combinations. We integrated functional assays for NK cells cultured in a variety of cytokine combinations with feature selection and mechanistic regression models. Our regression model successfully predicts NK cell proliferation for different cytokine combinations and indicates synergy between STAT3 and NF-{kappa}B transcription factors. Use of IL-21 in solution in the priming, but not post-priming phase of NK cell culture resulted in optimal NK cell proliferation, without compromising cytotoxicity or IFN-{gamma} secretion against hepatocellular carcinoma cell lines. Our work provides a mathematical framework for interrogating NK cell activation for cancer immunotherapy.
- organism: human
- assay: proteomics
- research focus: cell signaling & trafficking
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Unique Polyfunctional IL-33-responsive ST2⁺ NK cell State Potentiates Antitumor Immunity and Response to Immunotherapy
A. Eberhardt, E. Blanc, … N. Bendriss-Vermare·bioRxiv·Feb 14, 2023
- Enhancing network activation in Natural Killer cells: Predictions from in silico modeling
Sahak Z. Makaryan, Stacey D. Finley·Integrative BiologyPeer-reviewed·May 1, 2020
- Phospho-proteomics reveals that RSK signaling is required for proliferation of natural killer cells stimulated with IL-2 or IL-15
M. A. MacMullan, P. Wang, N. A. Graham·bioRxiv·Dec 17, 2021
- Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W. Matson, Robert Hullsiek, … Bruce K. Walcheck·Journal for ImmunoTherapy of CancerPeer-reviewed·Jul 1, 2024
- Advancing Adoptive Cell Therapy: Optimized Expansion of Adaptive NK Cells for Solid Tumors
Nerea Martín Almazán, Sara Roman, … Dhifaf Sarhan·bioRxiv·Oct 2, 2024
- Therapeutic blockade of Activin-A improves NK cell function and anti-tumor immunity
Jai Rautela, Laura F. Dagley, … Fernando Souza-Fonseca-Guimaraes·bioRxiv·Oct 29, 2018